| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Section of Endocrinology, Veterans Administration Hospital, and the Department of Medicine, University of Minnesota Minneapolis, Minnesota 55417
Address requests for reprints to: Dr. Frank Q. Nuttall, Section of Endocrinology, Veterans Administration Hospital, 54th Street and 48th Avenue South, Minneapolis, Minnesota 55417.
The prevalence of palpable gynecomastia was determined in 306 normal adult men ranging in age from 17-58 yr. Palpable breast tissue was present in 36% and was bilateral in all but 7 subjects. In the great majority of cases, the gynecomastia was 4 cm or less in diameter. A diameter greater than 5 cm was distinctly unusual. With advancing age there was a progressive increase in the prevalence of gynecomastia. This increase was most striking fn those over the age of 44 and in the 20- to 24-yr-old group compared to those 19 yr old or less. In those over the age of 44, the prevalence was 57%. These data indicate that palpable gynecomastic is common in normal adult men. This high prevalence must be taken into consideration when attributing gynecomastia to a drug or disease state. (J Clin Endocrinol Metab 48: 338, 1979)
Received February 27, 1978.
This article has been cited by other articles:
 |
|
 |
|
  C. B Niewoehner and A. E Schorer Gynaecomastia and breast cancer in men BMJ, March 29, 2008; 336(7646): 709 - 713. [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Braunstein Gynecomastia N. Engl. J. Med., September 20, 2007; 357(12): 1229 - 1237. [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Carlson, P. Kane, Z. M. Lei, X. Li, and C. V. Rao Presence of Luteinizing Hormone/Human Chorionic Gonadotropin Receptors in Male Breast Tissues J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4119 - 4123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bonat, A. Pathomvanich, M. F. Keil, A. E. Field, and J. A. Yanovski Self-Assessment of Pubertal Stage in Overweight Children Pediatrics, October 1, 2002; 110(4): 743 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Hayes and J. H. Eichhorn Case 12-2000- A 60-Year-Old Man with Persistent Gynecomastia after Excision of a Pituitary Adenoma N. Engl. J. Med., April 20, 2000; 342(16): 1196 - 1204. [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Appelbaum, G. F. F. Evans, K. R. Levy, R. H. Amirkhan, and T. D. Schumpert Mammographic Appearances of Male Breast Disease RadioGraphics, May 1, 1999; 19(3): 559 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Stratakis, A. Vottero, A. Brodie, L. S. Kirschner, D. DeAtkine, Q. Lu, W. Yue, C. S. Mitsiades, A. W. Flor, and G. P. Chrousos The Aromatase Excess Syndrome Is Associated with Feminization of Both Sexes and Autosomal Dominant Transmission of Aberrant P450 Aromatase Gene Transcription J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1348 - 1357. [Abstract] [Full Text]
|
|
|
|
|
|
L A G. Rodriguez and H Jick Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs BMJ, February 19, 1994; 308(6927): 503 - 506. [Abstract] [Full Text]
|
|
|
|
|
|
G. D. Braunstein Gynecomastia N. Engl. J. Med., February 18, 1993; 328(7): 490 - 495. [Full Text]
|
|
|
|
 |
|
 J. Cavanaugh, C. B. Niewoehner, and F. Q. Nuttall Gynecomastia and Cirrhosis of the Liver Arch Intern Med, March 1, 1990; 150(3): 563 - 565. [Abstract] [PDF]
|
|
|
|
|
|
L. A. Tanner and L. A. Bosco Gynecomastia Associated With Calcium Channel Blocker Therapy Arch Intern Med, February 1, 1988; 148(2): 379 - 380. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Kapoor Reversible Gynecomastia Associated With Sulindac Therapy JAMA, November 4, 1983; 250(17): 2284 - 2285. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
